Publications

Heinemann Klaas, Pauls Karl, Drug Utilization Study on the Prescribing Indications for CPA/EE (Cyproterone acetate 2mg in combination with Ethinylestradiol 35mcg) in 5 European Countries Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue S2, Pages 1-674.

Hagemann Christine, Heinemann Klaas, Möhner Sabine, Safety and efficacy of intrauterine devices: Baseline characteristics of 32,022 study participants from the EURAS-LCS12 study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.

Bauerfeind Anja, Barnett Clare, Do Minh Thai, Heinemann Klaas, The effect of BMI on unintended pregnancy rates amongst users of combined oral contraceptives Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.

Heinemann Klaas, Möhner Sabine, Reed Suzanne, Do Minh Thai, Unwanted pregnancies in women using Intrauterine Devices: final results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.

Heinemann Klaas, Möhner Sabine, Do Minh Thai, Reed Suzanne, Intrauterine Devices and the Risk of Uterine Perforations: Final Results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.

Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Impact of Estrogen Type on Cardiovascular Safety of Combined Oral Contraceptives Contraception. 2016; Oct;94(4):328-39. 10.1016/j.contraception.2016.06.010.

Barnett Clare, Hagemann Christine, Dinger Jürgen, Heinemann Klaas, Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study Eur J Contracept Reprod health Care. 2016; Oct 17:1-7. 10.1080/13625187.2016.1241991.

Barnett Clare, Bauerfeind Anja, Do Minh Thai, Heinemann Klaas, Influence of age and BMI on risk of venous thromboembolism: a meta-analysis of 246,513 women using combined oral contraceptives based on 521,516 women-years. Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Do Minh Thai, Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception. 2015; Apr;91(4):280-3. 10.1016/j.contraception.2015.01.011.

Bardenheuer Kristina, Dinger Jürgen, Hagemann Christine, Möhner Sabine, Franke Christian, Unintended pregnancies in users of different combined oral contraceptives - final results from the INAS-SCORE study. Pharmacoepidemiology and Drug Safety. 2015; 24 (S1): 1–587. 10.1002/pds.3838.

Bardenheuer Kristina, Heinemann Klaas, Do Minh Thai, Franke Christian, Cardiovascular Safety in Users of Different Combined Oral Contraceptives - Final Results from the INAS-SCORE study Pharmac. 2015; (24) S1, 1–587. 10.1002/pds.3838.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Do Minh Thai, Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception. 2015; 10.1016/j.contraception.2015.01.007.

Dinger Jürgen, Bardenheuer Kristina, Heinemann Klaas, Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception. 2014; Apr; 89(4): 253–63.. 10.1016/j.contraception.2014.01.023.

Reed Suzanne, Heinemann Klaas, Dinger Jürgen, Baseline risk factors for cardiovascular events: differences between the USA and Russia in a study population of combined oral contraceptives Pharmacoepidemiology and Drug Safety. 2014; Sep; 23(S1): 1-497. 10.1002/pds.3701.

Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Venous thromboemolism in users of a 24-day regimen of a combined oral contraceptive compare to conventional 21-day regimens: final results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.